Anti-CD19 CAR T cells potently redirected to kill solid tumor cells

• Christine Ambrose,

  Roles Investigation, Supervision, Writing – review & editing

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Lihe Su,

  Roles Investigation

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Lan Wu,

  Roles Investigation

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Fay J. Dufort,

  Roles Investigation

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Thomas Sanford,

  Roles Investigation

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Alyssa Birt,

  Roles Investigation

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Benjamin J. Hackel,

  Roles Investigation, Supervision

  Affiliation University of Minnesota, Minneapolis, MN, United States of America

  ⨯
• Andreas Hombach,

  Roles Investigation

  Affiliation University of Cologne, Köln, Germany

  ⨯
• Hinrich Abken,

  Roles Investigation, Supervision

  Current address: Regensburg University, Regensburg, Germany

  Affiliation University of Cologne, Köln, Germany

  ⨯
• Roy R. Lobb,

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  ⨯
• Paul D. Rennert

  Roles Conceptualization, Writing – original draft, Writing – review & editing

  * E-mail: paul.rennert@aletabio.com

  Affiliation Aleta Biotherapeutics, Natick, MA, United States of America

  https://orcid.org/0000-0002-4573-3764

  ⨯